Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 2, 2013, Pages 1522-1526

  Oldenburg, Catherine E ^a   Lalitha, Prajna ^b   Srinivasan, Muthiah ^b   Manikandan, Palanisamy ^b   Jayahar Bharathi, M ^b   Rajaraman, Revathi ^b   Ravindran, Meenakshi ^b   Mascarenhas, Jeena ^b   Nardone, Natalie ^a   Ray, Kathryn J ^a   Glidden, David V ^c   Acharya, Nisha R ^a,c   Lietman, Thomas M ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ARAVIND EYE CARE SYSTEM   (India)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFAZOLIN; MOXIFLOXACIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL KERATITIS; DISK DIFFUSION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY (TOPIC); NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL (TOPIC); STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; VISUAL ACUITY;

ADMINISTRATION, TOPICAL; ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; BACTERIA; CORNEAL ULCER; DISEASE SUSCEPTIBILITY; DOUBLE-BLIND METHOD; EYE INFECTIONS, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; OPHTHALMIC SOLUTIONS; PREDNISOLONE; QUINOLINES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84874963692     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-11246     Document Type: Article

References (24)

1. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004; 82:844-851.
2. Chen A, Prajna L, Srinivasan M, et al. Does In Vitro Susceptibility Predict Clinical Outcome in Bacterial Keratitis? Am J Ophthalmol. 2008;145:409-412.
3. Kaye S, Tuft S, Neal T, Tole D, Leeming J. Bacterial susceptibility to topical antimicrobials and clinical outcome in bacterial keratitis. Invest Ophthalmol Vis Sci. 2010;51:362-368.
4. Lalitha P, Prajna NV, Oldenburg CE, et al. Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial. Cornea. 2012;31:662-667.
5. Shapiro BL, Lalitha P, Loh AR. Susceptibility testing and clinical outcome in fungal keratitis. Br J Ophthalmol. 2010;94:384-385.
6. Lalitha P, Srinivasan M, Manikandan P, et al. Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis. Clin Infect Dis. 2012;54:1381-1387.
7. Wilhelmus KR, Abshire RL. Influence of fluoroquinolone susceptibility on the therapeutic response of fluoroquinolonetreated bacterial keratitis. Arch Ophthalmol. 2003;121:1229-1233.
8. Green M, Apel A, Stapleton F. Risk Factors and Causative Organisms in Microbial Keratitis. Cornea. 2008;27:22-27.
9. Srinivasan M, Mascarenhas J, Rajaraman R, et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics. Arch Ophthalmol. 2012;130:151-157.
10. Wilhelmus KR, Liesegang TJ, Osato MS. Laboratory diagnosis of ocular infections. In: Specter SC, ed. Cumitech. Washington, DC: American Society for Microbiology; 1994.
11. Preacher KJ, Hayes AF. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav Res Methods Instrum Comput. 2004;36:717-731.
12. Fleiszig SM, Evans DJ. The pathogenesis of bacterial keratitis: studies with Pseudomonas aeruginosa. Clin Exp Optom. 2002; 85:271-278.
13. Rex JH, Pfaller MA. Has antifungal susceptibility testing come of age? Clin Infect Dis. 2002;35:982-989.
14. Shah A, Sachdev A, Coggon D, Hossain P. Geographic variations in microbial keratitis: an analysis of the peerreviewed literature. Br J Ophthalmol. 2011;95:762-767.
15. Lichtinger A, Yeung SN, Kim P, et al. Shifting trends in bacterial keratitis in Toronto: an 11-year review. Ophthalmology. 2012; 119:1785-1790.
16. Bharathi MJ, Ramakrishnan R, Vasu S, Meenakshi R, Palaniappan R. Aetiological diagnosis of microbial keratitis in South India-A study of 1618 cases. Indian J Med Microbiol. 2002; 20:19-24.
17. Bharathi MJ, Ramakrishnan R, Meenakshi R, Padmavathy S, Shivakumar C, Srinivasan M. Microbial keratitis in South India: influence of risk factors, climate, and geographical variation. Ophthalmic Epidemiol. 2007;14:61-69.
18. Leck AK, Thomas PA, Hagan M, et al. Aetiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis. Br J Ophthalmol. 2002;86:1211-1215.
19. Dhakwa K, Sharma MK, Bajimaya S, Dwivedi AK, Rai SK. Causative organisms in microbial keratitis, their sensitivity pattern and treatment outcome in western Nepal. Nep J Oph. 2012;4:119-127.
20. de Rojas V, Llovet F, Marti{dotless}́nez M, et al. Infectious keratitis in 18, 651 laser surface ablation procedures. J Cataract Refract Surg. 2011;37:1822-1831.
21. Darugar A, Gaujoux T, Goldschmidt P. Clinical, microbiological, and therapeutic features of severe bacterial keratitis. J Fr Ophthalmol. 2011;34:362-368.
22. Prokosch V, Gatzioufas Z, Thanos S, Stupp T. Microbiological findings and predisposing risk factors in corneal ulcers. Graefes Arch Clin Exp Ophthalmol. 2011;250:369-374.
23. Srinivasan M, Mascarenhas J, Rajaraman R, et al. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol. 2012;130:143-150.
24. Hsu HY, Nacke R, Song JC, Yoo SH. Community opinions in the management of corneal ulcers and ophthalmic antibiotics: a survey of 4 states. Eye Contact Lens. 2010;36:195-200.